This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Roper Technologies (ROP) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Roper Technologies (ROP) delivered earnings and revenue surprises of 1.91% and 0.65%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Graham (GHM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Graham (GHM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Graham's (GHM) QTD Orders Worth $20M to Boost FY22 Revenues
by Zacks Equity Research
Graham's (GHM) orders of $20 million so far in second-quarter fiscal 2022 reflect improving demand, mainly in the defense market. Awarded contracts are to contribute to fiscal 2022 revenues.
Graham (GHM) Boosts Defense Business With Barber-Nichols Buyout
by Zacks Equity Research
Graham's (GHM) buyout of Barber-Nichols is anticipated to enhance the company's business in the defense sector. The acquisition is expected to be accretive to revenues and earnings in fiscal 2022.
Graham (GHM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Graham (GHM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Graham (GHM) Q3 Earnings Lag Estimates
by Zacks Equity Research
Graham (GHM) delivered earnings and revenue surprises of -8.33% and 9.58%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Manufacturing Revenues Poised to Increase: 5 Solid Picks
by Ritujay Ghosh
Steady growth in manufacturing activity is expected through 2021 and is likely to help companies like ParkerHannifin Corporation (PH), AGCO Corporation (AGCO) and Graco (GGG).
Colfax's (CFX) Unit Closes Buyout of Trilliant Surgical
by Zacks Equity Research
Colfax (CFX) arm DJO closes buyout of Trilliant Surgical, which will boost its product offerings and growth prospects in the foot and ankle surgery market.
New Strong Buy Stocks for January 21st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
The Zacks Analyst Blog Highlights: Myers Industries, Deere & Co, Graham, AGCO and Mueller Industries
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Myers Industries, Deere & Co, Graham, AGCO and Mueller Industries
5 Top-Ranked Industrial Stocks to Buy for Solid Upside in 2021
by Tirthankar Chakraborty
The U.S. manufacturing sector is regaining strength on rising industrial output in December. This calls for investing in industrial stocks like Myers Industries (MYE), Deere (DE) and AGCO.
Graham (GHM) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Graham (GHM) delivered earnings and revenue surprises of 170.00% and 19.41%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Graham (GHM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Graham (GHM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Graham (GHM) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Graham (GHM) delivered earnings and revenue surprises of -28.57% and 15.40%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Graham (GHM) Q1 Earnings Expected to Decline
by Zacks Equity Research
Graham (GHM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Graham (GHM) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Graham (GHM) delivered earnings and revenue surprises of -14.29% and -14.76%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Graham (GHM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Graham (GHM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Graham (GHM) Reports Break-Even Earnings for Q3
by Zacks Equity Research
Graham (GHM) delivered earnings and revenue surprises of -100.00% and -10.84%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Graham (GHM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Graham (GHM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Graham Corporation (GHM) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Graham Corporation (GHM).
Colfax (CFX) Q3 Earnings Beat Estimates, Up Y/Y on Buyouts
by Zacks Equity Research
Colfax's (CFX) third-quarter 2019 results benefit from improved sales performance, with buyouts playing a significant role.
Applied Industrial (AIT) Q1 Earnings Beat, Macro Woes Persist
by Zacks Equity Research
End-market challenges adversely impact Applied Industrial's (AIT) fiscal first-quarter sales on a year-over-year basis. This might continue to affect its performance through the rest of fiscal 2020.
Xylem (XYL) Meets Q3 Earnings Estimates, Lowers '19 View
by Zacks Equity Research
Xylem's (XYL) third-quarter 2019 earnings meet estimates but rise year over year on solid organic sales and improved margins. The company lowers 2019 earnings projection.
Flowserve (FLS) Beats Q3 Earnings Estimates, Revises View
by Zacks Equity Research
Flowserve's (FLS) third-quarter 2019 earnings benefit from sales growth, margin improvement and decline in interest expenses. It revises projections for 2019.
IDEX (IEX) Beats Q3 Earnings Estimates, Lowers Organic View
by Zacks Equity Research
IDEX's (IEX) third-quarter 2019 results gain from productivity initiatives. Organic performance suffers from global worries, leading to a revision in 2019 projections.